Driven by non-recurring listing and acquisition fees of €2.1m, Aladdin reported an H1 net loss of €2.8m in its first set of interim results. Separately, the company has successfully uplisted to the regulated segment of the Düsseldorf exchange, while it continues to add electronic health records to its big data platform. Aladdin expects maiden revenues in H2, in addition to the launch of prototypes for its proof-of-concept blockchain ecosystem. The company had cash of €750k at end H118, wi...
Aladdin has issued a series of updates on its progress with the development and implementation of its technology suite. Perhaps most significantly, it has launched its prototype blockchain network and is now adding some quarter of a million electronic health records (EHR) to the platform. Separately, Aladdin has announced a prototype for the diagnosis of diabetic retinopathy, with early analysis indicating that accuracy is similar to, or better than, humans. Information on the commercial aspects...
Unfortunately, this report is not available for the investor type or country you selected.
Report is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.